Cargando…
Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke
Health risk associated with the use of combustible cigarettes is well characterized and numerous epidemiological studies have been published for many years. Since more than a decade, innovative non-combusted tobacco products have emerged like heated tobacco products (HTP) or electronic cigarettes (E...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811518/ https://www.ncbi.nlm.nih.gov/pubmed/33025067 http://dx.doi.org/10.1007/s00204-020-02924-x |
_version_ | 1783637515378360320 |
---|---|
author | Rodrigo, Gregory Jaccard, Guy Tafin Djoko, Donatien Korneliou, Alexandra Esposito, Marco Belushkin, Maxim |
author_facet | Rodrigo, Gregory Jaccard, Guy Tafin Djoko, Donatien Korneliou, Alexandra Esposito, Marco Belushkin, Maxim |
author_sort | Rodrigo, Gregory |
collection | PubMed |
description | Health risk associated with the use of combustible cigarettes is well characterized and numerous epidemiological studies have been published for many years. Since more than a decade, innovative non-combusted tobacco products have emerged like heated tobacco products (HTP) or electronic cigarettes (EC). Long-term effects of these new products on health remain, however, unknown and there is a need to characterize associated potential health risks. The time dedicated to epidemiological data generation (at least 20 to 40 years for cancer endpoint), though, is not compatible with innovative development. Surrogates need, therefore, to be developed. In this work, non-cancer and cancer risks were estimated in a range of HTP and commercial combustible cigarettes based upon their harmful and potentially harmful constituent yields in aerosols and smoke, respectively. It appears that mean lifetime cancer risk values were decreased by more than one order of magnitude when comparing HTPs and commercial cigarettes, and significantly higher margin of exposure for non-cancer risk was observed for HTPs when compared to commercial cigarettes. The same approach was applied to two commercial ECs. Similar results were also found for this category of products. Despite uncertainties related to the factors used for the calculations and methodological limitations, this approach is valuable to estimate health risks associated to the use of innovative products. Moreover, it acts as predictive tool in absence of long-term epidemiological data. Furthermore, both cancer and non-cancer risks estimated for HTPs and ECs highlight the potential of reduced risk for non-combusted products when compared to cigarette smoking. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-020-02924-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7811518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-78115182021-01-25 Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke Rodrigo, Gregory Jaccard, Guy Tafin Djoko, Donatien Korneliou, Alexandra Esposito, Marco Belushkin, Maxim Arch Toxicol Genotoxicity and Carcinogenicity Health risk associated with the use of combustible cigarettes is well characterized and numerous epidemiological studies have been published for many years. Since more than a decade, innovative non-combusted tobacco products have emerged like heated tobacco products (HTP) or electronic cigarettes (EC). Long-term effects of these new products on health remain, however, unknown and there is a need to characterize associated potential health risks. The time dedicated to epidemiological data generation (at least 20 to 40 years for cancer endpoint), though, is not compatible with innovative development. Surrogates need, therefore, to be developed. In this work, non-cancer and cancer risks were estimated in a range of HTP and commercial combustible cigarettes based upon their harmful and potentially harmful constituent yields in aerosols and smoke, respectively. It appears that mean lifetime cancer risk values were decreased by more than one order of magnitude when comparing HTPs and commercial cigarettes, and significantly higher margin of exposure for non-cancer risk was observed for HTPs when compared to commercial cigarettes. The same approach was applied to two commercial ECs. Similar results were also found for this category of products. Despite uncertainties related to the factors used for the calculations and methodological limitations, this approach is valuable to estimate health risks associated to the use of innovative products. Moreover, it acts as predictive tool in absence of long-term epidemiological data. Furthermore, both cancer and non-cancer risks estimated for HTPs and ECs highlight the potential of reduced risk for non-combusted products when compared to cigarette smoking. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-020-02924-x) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-10-06 2021 /pmc/articles/PMC7811518/ /pubmed/33025067 http://dx.doi.org/10.1007/s00204-020-02924-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Genotoxicity and Carcinogenicity Rodrigo, Gregory Jaccard, Guy Tafin Djoko, Donatien Korneliou, Alexandra Esposito, Marco Belushkin, Maxim Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke |
title | Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke |
title_full | Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke |
title_fullStr | Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke |
title_full_unstemmed | Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke |
title_short | Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke |
title_sort | cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke |
topic | Genotoxicity and Carcinogenicity |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811518/ https://www.ncbi.nlm.nih.gov/pubmed/33025067 http://dx.doi.org/10.1007/s00204-020-02924-x |
work_keys_str_mv | AT rodrigogregory cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke AT jaccardguy cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke AT tafindjokodonatien cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke AT kornelioualexandra cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke AT espositomarco cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke AT belushkinmaxim cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke |